Skip to content
Clinical Trials – home

Hospital Universitario De La Plana

Research site

Spain Carretera De Vila-Real A Burriana Km 0.5, 12540 Villarreal, Spain

  • 6 trials recruiting
  • Asthma · Conjunctivitis allergic · Mite allergy
  • Adults and children

About Specializations

Hospital Universitario De La Plana in Villarreal, Spain specialises in clinical trials of conditions such as Asthma, Conjunctivitis allergic, Mite allergy, Chronic spontaneous urticaria, and other specialisations. This site conducts important research.

Main research areas of the site

Respiratory and Allergic Disease Research

At Hospital Universitario De La Plana, clinical trials in respiratory tract diseases and immune system diseases focus on allergic rhinitis, rhinoconjunctivitis, and asthma. These studies are designed to assess new immunotherapy approaches and compare how well they control allergy-related symptoms in people sensitized to house dust mites.

  • Evaluating immunotherapy for allergic rhinitis and rhinoconjunctivitis caused by house dust mite exposure
  • Studying treatment options for severe asthma with an eosinophilic phenotype
  • Assessing the clinical benefit of allergy-targeted therapies in persistent respiratory allergy

This area of research aims to improve symptom control, long-term management, and treatment effectiveness for patients with chronic allergic airway conditions.

Skin and Immune-Mediated Conditions

The site also conducts trials in skin and connective tissue diseases and immune system diseases, with a strong emphasis on chronic spontaneous urticaria. Research here is exploring whether newer therapies can better reduce hives and improve day-to-day comfort for people living with persistent allergic skin disease.

  • Testing a new treatment for chronic spontaneous urticaria
  • Measuring improvements in urticaria activity and symptom control
  • Exploring longer-term disease stability and treatment response

These studies are centered on finding safer and more effective ways to manage recurring skin symptoms and reduce disease burden.

Women’s Health and Perioperative Care

Research in female urogenital diseases and pregnancy complications at this hospital includes studies related to childbirth recovery and pain relief. One key focus is the management of first-degree perineal laceration, with the goal of improving comfort and supporting better repair outcomes after delivery.

  • Comparing pain relief options for perineal tear repair after childbirth
  • Evaluating approaches that may improve immediate postpartum comfort
  • Supporting better recovery in women after delivery-related injury

This work reflects the site’s interest in practical, patient-centered improvements in obstetric care and postoperative pain management.

Oncology and Surgical Pain Management

In neoplasms, the clinical research includes breast cancer and related surgical care. Trials are examining ways to improve analgesia during and after surgery, with the aim of making recovery more comfortable and supporting better treatment experiences for patients undergoing cancer operations.

  • Studying pain control strategies in breast cancer surgery
  • Comparing methods used to support postoperative comfort
  • Evaluating whether new pain-management options can improve recovery

This line of research combines oncology with anesthesia expertise to strengthen supportive care around surgical treatment.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Carretera De Vila-Real A Burriana Km 0.512540 VillarrealSpain
Recruiting now
6 trials
Conditions studied
8

More sites in VillarrealSpain

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

12 clinical trials

A study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.

Breast cancer

Recruiting

Comparing magnesium sulfate and dexmedetomidine combined with ropivacaine for pain relief after breast cancer surgery in women undergoing mastectomy

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Dexmedetomidine
  • Sponsor:Fundacion Para El Fomento De La Investigacion Sanitaria Y Biomedica De La Comunitat Valenciana

Study on the Effectiveness and Safety of Mannan-Conjugated Allergoids for Treating Allergic Rhinitis/Rhinoconjunctivitis in Patients Allergic to House Dust Mites

Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dermatophagoides farinae enriched allergoid, mannan-conjugated, polymerised
  • Sponsor:Inmunotek S.L.

Perineal injury

Recruiting

Comparing Lidocaine-Prilocaine Cream and Lidocaine Injection for First-Degree Perineal Tear Repair in Women

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Lidocaine
  • Sponsor:Fundacion Para El Fomento De La Investigacion Sanitaria Y Biomedica De La Comunitat Valenciana

Asthma

Recruiting

Study on Tezepelumab for Children Aged 5 to 11 with Severe Asthma

Registered drug
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Tezepelumab
  • Sponsor:AstraZeneca AB

Mite allergy

Recruiting

Study on the Effectiveness and Safety of Beltavac for Patients with Allergic Rhinitis from House Dust Mites

Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Mixture Of Allergen Extracts Of Dermatophagoides Pteronyssinus And Dermatophagoides Farinae Polymerized With Glutaraldehyde
  • Sponsor:Probelte Pharma S.L.

Mite allergy

Not yet recruiting

Efficacy and safety of house dust mite allergoid (Dermatophagoides farinae, D. pteronyssinus, aluminium hydroxide) in people with moderate to severe house dust mite allergy

Registered drug
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Aluminium Hydroxide

Conjunctivitis allergic+1

Not yet recruiting

Diagnostic Accuracy of Parietaria judaica Pollen Extract (SPT‑RX) in a Skin Prick Test Drug Combination for Adults with Allergic Rhinitis and Controlled Mild Asthma

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Betula Pendula Pollen Extract
  • Sponsor:ROXALL Medizin GmbH

Study on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.

Conjunctivitis allergic+1

Not recruiting

Study on the Safety and Effectiveness of Subcutaneous Immunotherapy with Der p 1, Der p 2, and Der p 23 Allergens for Patients with Allergic Rhinitis or Rhinoconjunctivitis

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Dermatophagoides Pteronyssinus
  • Sponsor:Diater Laboratorio De Diagnostico Y Aplicaciones Terapeuticas S.A.

Asthma

Not recruiting

Study Comparing Depemokimab, Mepolizumab, and Benralizumab for Adults and Adolescents with Severe Eosinophilic Asthma

Registered drug
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Benralizumab
  • Sponsor:Glaxosmithkline Research & Development Limited

Asthma

Not recruiting

Study on the Effectiveness and Safety of Tanimilast for Patients with Uncontrolled Asthma on Inhaled Corticosteroid and Long-Acting Beta2-Agonist Therapy

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Tanimilast
  • Sponsor:Chiesi Farmaceutici S.p.A.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.